Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BBLE37
|
|||
| Binder Name |
Varenicline
|
|||
| Synonyms |
6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-; CP-526555; 6,7,8,9-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine; CHEMBL556954; 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; NCGC00247735-01; NCGC00247735-02; Varenicline (INN); CP-526,555; CHEMBL1396; SCHEMBL225687; CP 526555; Champix; Chantix; BCP01413; BDBM50166908; 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine,7,8,9,10-tetrahydro-; AKOS005145561; CS-0396; DB01273; MCULE-3341459784; SB17430; NCGC00247735-03; HY-10019; DB-015064; D08669; AB01568242_01; J-501695; Q56433825; 7,8,9,10-tetrahydro- 6,10-methano- 6H-pyrazino (2,3-h)(3) benzazepine; 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino-[2,3-h][3]benzazepine; 2-AMINO-4-(TRIFLUOROMETHYL)THIOPHENOL3-AMINO-4-MERCAPTOBENZOTRIFLUORIDE; 5,8,14-Triazatetracyclo[10.3.1.02, 11.04,9]hexadeca-2(11),3,5,7,9-pentaene; 5,8,14-Triazatetracyclo[10.3.1.02,11,04,9]hexadeca-2(11),3,5,7,9-pentaene; 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene; 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9pentaene; 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2(11),3,5,7,9-pentaene; 6,10-Methano-7,8,9,10-tetrahydro-1,4,8-triaza-6H-cyclohepta[b]naphthalene; 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine(Varenicline)
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H13N3
|
|||
| Canonical SMILES |
C1C2CNCC1C3=CC4=NC=CN=C4C=C23
|
|||
| InChI |
1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2
|
|||
| InChIKey |
JQSHBVHOMNKWFT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.